What is it about?
a unified synthetic route to the chiral framework of the 19-epi-BE-43547 series was developed.
Featured Image
Photo by Chromatograph on Unsplash
Why is it important?
Studies revealed that BE-43547 A2 and Rakicidin A have shown significantly enhanced cytotoxicity against hypoxic cancer cells when compared to a series of well-established toxic compounds including Taxol.
Perspectives
A short and enantioselective synthesis of the 19-epi-BE-43547 A2 chiral framework has been achieved in a high yield.
Dr. Kranthi Kumar Ramagonolla
Harvard University
Read the Original
This page is a summary of: Toward the synthesis of the hypoxia selective anticancer agent BE-43547 A2, Organic & Biomolecular Chemistry, January 2021, Royal Society of Chemistry,
DOI: 10.1039/d1ob01824h.
You can read the full text:
Contributors
The following have contributed to this page
